Understanding Burholderia cepacia: Epidemiology, genomovars, and virulence

Infections in Medicine

Volumn 18, Issue 1, 2001, Pages 49-56

  Speert, D P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Burkholderia; Cystic fibrosis

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CEFTAZIDIME; CEFTAZIDIME ARGININE; CILASTATIN PLUS IMIPENEM; CORTISPORIN; COTRIMOXAZOLE; GENTAMICIN; HEMOLYSIN; IMIPENEM; MELANIN; MEROPENEM; NEOSPORIN; PHOSPHOLIPASE C; POLYMYXIN; PROTEINASE; SIDEROPHORE; TOBRAMYCIN; TOBRAMYCIN SULFATE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL VIRULENCE; BACTERIUM PILUS; BURKHOLDERIA CEPACIA; CHRONIC GRANULOMATOUS DISEASE; CYSTIC FIBROSIS; DRUG CHOICE; GRAM NEGATIVE INFECTION; HUMAN; INFECTION RISK; LUNG INFECTION; REVIEW; STRAIN DIFFERENCE;

EID: 0035145513     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov.
2. Genomic complexity and plasticity of Burkholderia cepacia
3. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis
4. Intercontinental spread of a highly transmissible clone of Pseudomonas cepacia proved by multilocus enzyme electrophoresis and ribotyping
5. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis
6. Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis
7. Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis
8. Pseudomonas cepacia: Biology, mechanisms of virulence, epidemiology
9. Infection with Pseudomonas cepacia in chronic granulomatous disease: Role of nonoxidative killing by neutrophils in host defense
10. Virulence factors of Burkholderia cepacia
11. Microbial pathogenesis in cystic fibrosis: Mucoid Pseudomonas aeruginosa and Burkholderia cepacia
12. Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia
13. Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide
14. Pseudomonas cepacia infection in cystic fibrosis: An emerging problem
15. Determinants of mortality from cystic fibrosis in Canada, 1970-1989
16. Burkholderia cepacia: Medical, taxonomic and ecological issues
17. Agricultural use of Burkholderia (Pseudomonas) cepacia: A threat to human health?
18. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp nov
19. Identification and population structure of Burkholderla stabilis sp nov (formerly Burkholderia cepacia genomovar IV)
20. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis
21. Intracellular survival and saprophytic growth of isolates from the Burkholderia cepacia complex in free-living amoebae
22. Multifactorial pathogenic mechanisms of Burkholderia pseudomallei as suggested from comparison with Burkholderia cepacia
23. Pseudomonas aeruginosa and Pseudomonas cepacia isolated from cystic fibrosis patients bind specifically to gangliotetraosylceramide (Asialo GM1) and gangliotriaosylceramide (Asialo GM2)
24. Identification of the mucin-binding adhesin of Pseudomonas cepacia isolated from patients with cystic fibrosis
25. Pseudomonas cepacia adherence to respiratory epithelial cells is enhanced by Pseudomonas aeruginosa
26. Binding of Pseudomonas cepacia to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis
27. + Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain
28. Purification and characterization of an extracellular protease from Pseudomonas cepacia
29. Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes
30. A nonhemolytic phospholipase C from Burkholderia
31. Siderophore production by cystic fibrosis isolates of Burkholderia cepacia
32. Characterization of Pseudomonas cepacia isolates from patients with cystic fibrosis
33. Characterization of a Burkholderia cepacia mutant with altered membrane permeability and increased susceptibility to cationic antimicrobial agents
34. A melanin pigment from an epidemic strain of Burkholderia cepacia attenuates monocyte respiratory burst activity by scavenging superoxide anion
35. Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers
36. Molecular epidemiology of Burkholderia cepacia using random amplified polymorphic DNA (RAPD) analysis
37. An epidemic of Burkholderia cepacia transmitted between patients with and without cystic fibrosis
38. Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis
39. Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak
40. Misidentification of Xanthamonas maltophilia as Pseudomonas cepacia in the sputum of patients with cystic fibrosis: A diagnostic pitfall with major clinical implications
41. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium
42. Multiple combination bactericidal antibiotic testing in cystic fibrosis patients infected with Burkholderia cepacia
43. Sour skin, a bacterial rot of onion bulbs
44. Biological control of Aphanomyces root rot and Pythium damping-off of peas by application of Pseudomonas cepacia or Pseudomonas fiuorescens applied to seed
45. Phylogenetic perspectives on innate immunity
46. Type III secretion machines: Bacterial devices for protein delivery into host cells